Janney Montgomery Scott LLC Ionis Pharmaceuticals Inc Transaction History

Janney Montgomery Scott LLC

$35.8 Billion
Q3 2024

A detailed history of Janney Montgomery Scott LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 11,294 shares of IONS stock, worth $410,311. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,294

Previous 17,534 35.59%

Holding current value

$410,311

Previous $836,000 45.93%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$40.06 - $51.86 $249,974 - $323,606	-6,240 Reduced 35.59%	11,294 $452,000
Q2 2024 Jul 25, 2024	SELL	$36.45 - $47.7 $341,135 - $446,424	-9,359 Reduced 34.8%	17,534 $836,000
Q1 2024 May 01, 2024	SELL	$42.03 - $53.55 $62,456 - $79,575	-1,486 Reduced 5.24%	26,893 $1.17 Million
Q4 2023 Feb 07, 2024	SELL	$43.39 - $51.63 $53,760 - $63,969	-1,239 Reduced 4.18%	28,379 $1.44 Million
Q3 2023 Nov 08, 2023	SELL	$38.5 - $47.13 $57,172 - $69,988	-1,485 Reduced 4.77%	29,618 $1.34 Million
Q2 2023 Jul 26, 2023	SELL	$34.73 - $43.33 $52,268 - $65,211	-1,505 Reduced 4.62%	31,103 $1.28 Million
Q1 2023 Apr 28, 2023	SELL	$33.58 - $41.2 $15,111 - $18,540	-450 Reduced 1.36%	32,608 $1.17 Million
Q4 2022 Feb 01, 2023	BUY	$37.12 - $46.52 $23,868 - $29,912	643 Added 1.98%	33,058 $1.25 Million
Q3 2022 Oct 25, 2022	BUY	$36.54 - $48.66 $64,200 - $85,495	1,757 Added 5.73%	32,415 $1.43 Million
Q2 2022 Aug 03, 2022	SELL	$31.71 - $43.0 $252,284 - $342,108	-7,956 Reduced 20.6%	30,658 $1.14 Million
Q1 2022 May 04, 2022	BUY	$29.88 - $37.04 $65,437 - $81,117	2,190 Added 6.01%	38,614 $1.43 Million
Q4 2021 Jan 27, 2022	BUY	$25.61 - $35.1 $58,160 - $79,712	2,271 Added 6.65%	36,424 $1.11 Million
Q3 2021 Oct 29, 2021	SELL	$33.54 - $40.55 $150,695 - $182,191	-4,493 Reduced 11.63%	34,153 $1.15 Million
Q2 2021 Jul 26, 2021	BUY	$34.54 - $47.25 $63,346 - $86,656	1,834 Added 4.98%	38,646 $1.54 Million
Q1 2021 Apr 27, 2021	BUY	$42.51 - $63.78 $35,665 - $53,511	839 Added 2.33%	36,812 $1.66 Million
Q4 2020 Jan 25, 2021	SELL	$45.3 - $60.27 $63,510 - $84,498	-1,402 Reduced 3.75%	35,973 $2.03 Million
Q3 2020 Nov 06, 2020	SELL	$47.45 - $62.95 $50,249 - $66,664	-1,059 Reduced 2.76%	37,375 $1.77 Million
Q2 2020 Jul 23, 2020	SELL	$46.85 - $61.05 $72,430 - $94,383	-1,546 Reduced 3.87%	38,434 $2.27 Million
Q1 2020 Apr 30, 2020	SELL	$41.6 - $63.4 $132,870 - $202,499	-3,194 Reduced 7.4%	39,980 $1.89 Million
Q4 2019 Jan 21, 2020	SELL	$53.85 - $65.27 $85,890 - $104,105	-1,595 Reduced 3.56%	43,174 $2.61 Million
Q3 2019 Oct 29, 2019	SELL	$59.06 - $72.15 $4.71 Million - $5.75 Million	-79,737 Reduced 64.04%	44,769 $2.68 Million
Q2 2019 Jul 29, 2019	BUY	$62.09 - $86.14 $258,232 - $358,256	4,159 Added 3.46%	124,506 $8 Million
Q1 2019 Apr 30, 2019	BUY	$52.92 - $81.17 $3.63 Million - $5.57 Million	68,651 Added 132.8%	120,347 $9.77 Million
Q4 2018 Feb 01, 2019	BUY	$43.37 - $59.54 $24,026 - $32,985	554 Added 1.08%	51,696 $2.8 Million
Q3 2018 Nov 05, 2018	SELL	$42.88 - $53.7 $24,270 - $30,394	-566 Reduced 1.09%	51,142 $2.64 Million
Q2 2018 Jul 24, 2018	BUY	$40.53 - $50.7 $99,744 - $124,772	2,461 Added 5.0%	51,708 $2.16 Million
Q1 2018 Apr 19, 2018	BUY	$44.08 - $55.05 $16,530 - $20,643	375 Added 0.77%	49,247 $2.17 Million
Q4 2017 Feb 14, 2018	BUY	$50.3 - $64.39 $292,645 - $374,621	5,818 Added 13.51%	48,872 $2.46 Million
Q3 2017 Nov 15, 2017	BUY	$45.56 - $59.57 $1.96 Million - $2.56 Million	43,054	43,054 $2.18 Million

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.16B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Account

Janney Montgomery Scott LLC Ionis Pharmaceuticals Inc Transaction History